Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.

Weidmann M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj I, El-Sanousi A, Elaldi N, Hewson R, Hufert FT, Humolli I, Jansen van Vuren P, Koçak Tufan Z, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, Ozkul A, Papa A, Paweska J, Sall AA, Schmaljohn CS, Swanepoel R, Uyar Y, Weber F, Zeller H.

J Gen Virol. 2016 Nov;97(11):2799-2808. doi: 10.1099/jgv.0.000610. Epub 2016 Sep 19.

PMID:
27667586
2.

Crimean-Congo haemorrhagic fever.

Peyrefitte C, Marianneau P, Tordo N, Bouloy M.

Rev Sci Tech. 2015 Aug;34(2):391-401.

3.

In memoriam--Richard M. Elliott (1954-2015).

Brennan B, Weber F, Kormelink R, Schnettler E, Bouloy M, Failloux AB, Weaver SC, Fazakerley JK, Fragkoudis R, Harris M, Barr JN, Palese P, García-Sastre A, Dalziel RG, Dutia BM, Lowen AC, Steel J, Randall RE, Paul Duprex W, Rice CM, Tesh RB, Murphy FA, Ebihara H, Vasconcelos PF, Nunes MR, Fooks AR, Smith GL, Goodfellow I, Pappu HR, Lamb RA, Paterson RG, Higgs S, Vanlandingham DL, Dietzgen RG, Stephen Lodmell J, Nichol ST, Daly J, Ullman DE, Plyusnin A, Plyusnina A, Efstathiou S, Hewson R, Tordo N, Cherry S, Boutell C, Hosie MJ, Murcia PR, Neil JC, Palmarini M, Patel AH, Willett BJ, Kohl A, McLauchlan J.

J Gen Virol. 2015 Aug;96(8):1975-8. doi: 10.1099/jgv.0.000241. No abstract available.

4.

The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts.

Kreher F, Tamietti C, Gommet C, Guillemot L, Ermonval M, Failloux AB, Panthier JJ, Bouloy M, Flamand M.

Emerg Microbes Infect. 2014 Oct;3(10):e71. doi: 10.1038/emi.2014.71. Epub 2014 Oct 1.

5.

The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

Tokuda S, Do Valle TZ, Batista L, Simon-Chazottes D, Guillemot L, Bouloy M, Flamand M, Montagutelli X, Panthier JJ.

Genes Immun. 2015 Apr-May;16(3):206-12. doi: 10.1038/gene.2014.79. Epub 2015 Jan 8.

6.

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.

Vaccine. 2014 Sep 3;32(39):4901-8. doi: 10.1016/j.vaccine.2014.07.037. Epub 2014 Jul 19.

PMID:
25050973
7.

Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity.

Le Coupanec A, Babin D, Bouloy M, Choumet V.

Microbes Infect. 2014 May;16(5):439-44. doi: 10.1016/j.micinf.2014.01.008. Epub 2014 Feb 13.

PMID:
24530502
8.

Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis.

Carnec X, Ermonval M, Kreher F, Flamand M, Bouloy M.

Virology. 2014 Jan 5;448:1-14. doi: 10.1016/j.virol.2013.09.023. Epub 2013 Oct 16.

9.

Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.

Le Coupanec A, Babin D, Fiette L, Jouvion G, Ave P, Misse D, Bouloy M, Choumet V.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2237. doi: 10.1371/journal.pntd.0002237. Print 2013.

10.

International external quality assessment of molecular detection of Rift Valley fever virus.

Escadafal C, Paweska JT, Grobbelaar A, le Roux C, Bouloy M, Patel P, Teichmann A, Donoso-Mantke O, Niedrig M.

PLoS Negl Trop Dis. 2013 May 23;7(5):e2244. doi: 10.1371/journal.pntd.0002244. Print 2013.

11.

Vaccination for the control of Rift Valley fever in enzootic and epizootic situations.

Dungu B, Donadeu M, Bouloy M.

Dev Biol (Basel). 2013;135:61-72. doi: 10.1159/000157178. Epub 2013 May 14.

PMID:
23689884
12.

Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells.

Léger P, Lara E, Jagla B, Sismeiro O, Mansuroglu Z, Coppée JY, Bonnefoy E, Bouloy M.

J Virol. 2013 Feb;87(3):1631-48. doi: 10.1128/JVI.02795-12. Epub 2012 Nov 21.

13.

First serologic evidence for the circulation of Crimean-Congo hemorrhagic fever virus in Romania.

Ceianu CS, Panculescu-Gatej RI, Coudrier D, Bouloy M.

Vector Borne Zoonotic Dis. 2012 Sep;12(9):718-21. doi: 10.1089/vbz.2011.0768. Epub 2012 Aug 16.

PMID:
22897346
14.

Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.

Benferhat R, Josse T, Albaud B, Gentien D, Mansuroglu Z, Marcato V, Souès S, Le Bonniec B, Bouloy M, Bonnefoy E.

J Virol. 2012 Oct;86(20):11333-44. Epub 2012 Aug 15.

15.

Genome analysis of Rift Valley fever virus, Mayotte.

Cêtre-Sossah C, Zeller H, Grandadam M, Caro V, Pettinelli F, Bouloy M, Cardinale E, Albina E.

Emerg Infect Dis. 2012 Jun;18(6):969-71. doi: 10.3201/eid1806.110994.

16.

Prevalence of Rift Valley Fever among ruminants, Mayotte.

Cêtre-Sossah C, Pédarrieu A, Guis H, Defernez C, Bouloy M, Favre J, Girard S, Cardinale E, Albina E.

Emerg Infect Dis. 2012 Jun;18(6):972-5. doi: 10.3201/eid1806.111165.

17.

MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines.

Ayari-Fakhfakh E, do Valle TZ, Guillemot L, Panthier JJ, Bouloy M, Ghram A, Albina E, Cêtre-Sossah C.

J Gen Virol. 2012 Jul;93(Pt 7):1456-64. doi: 10.1099/vir.0.042754-0. Epub 2012 Apr 18.

PMID:
22513390
18.

Searching for cellular partners of hantaviral nonstructural protein NSs: Y2H screening of mouse cDNA library and analysis of cellular interactome.

Rönnberg T, Jääskeläinen K, Blot G, Parviainen V, Vaheri A, Renkonen R, Bouloy M, Plyusnin A.

PLoS One. 2012;7(4):e34307. doi: 10.1371/journal.pone.0034307. Epub 2012 Apr 10.

19.

Association of the interferon-β gene with pericentromeric heterochromatin is dynamically regulated during virus infection through a YY1-dependent mechanism.

Josse T, Mokrani-Benhelli H, Benferhat R, Shestakova E, Mansuroglu Z, Kakanakou H, Billecocq A, Bouloy M, Bonnefoy E.

Nucleic Acids Res. 2012 May;40(10):4396-411. doi: 10.1093/nar/gks050. Epub 2012 Jan 28.

20.

Serological evaluation of Crimean-Congo hemorrhagic fever in humans with high-risk professions living in enzootic regions of Isfahan province of Iran and genetic analysis of circulating strains.

Chinikar S, Ghiasi SM, Naddaf S, Piazak N, Moradi M, Razavi MR, Afzali N, Haeri A, Mostafavizadeh K, Ataei B, Khalilifard-Brojeni M, Husseini SM, Bouloy M.

Vector Borne Zoonotic Dis. 2012 Sep;12(9):733-8. doi: 10.1089/vbz.2011.0634. Epub 2012 Jan 4.

21.

Antiviral escape strategies developed by bunyaviruses pathogenic for humans.

Le May N, Bouloy M.

Front Biosci (Schol Ed). 2012 Jan 1;4:1065-77. Review.

PMID:
22202109
22.

Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Gommet C, Billecocq A, Jouvion G, Hasan M, Zaverucha do Valle T, Guillemot L, Blanchet C, van Rooijen N, Montagutelli X, Bouloy M, Panthier JJ.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1421. doi: 10.1371/journal.pntd.0001421. Epub 2011 Dec 6.

23.

The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Fernandez JC, Billecocq A, Durand JP, Cêtre-Sossah C, Cardinale E, Marianneau P, Pépin M, Tordo N, Bouloy M.

Clin Vaccine Immunol. 2012 Jan;19(1):5-10. doi: 10.1128/CVI.05420-11. Epub 2011 Nov 9.

24.

Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.

Lara E, Billecocq A, Leger P, Bouloy M.

J Virol. 2011 Dec;85(23):12134-45. doi: 10.1128/JVI.05322-11. Epub 2011 Sep 14.

25.

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M.

J Virol. 2011 Nov;85(22):12093-7. doi: 10.1128/JVI.00429-11. Epub 2011 Aug 31.

26.

DC-SIGN as a receptor for phleboviruses.

Lozach PY, Kühbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A.

Cell Host Microbe. 2011 Jul 21;10(1):75-88. doi: 10.1016/j.chom.2011.06.007.

27.

Rift valley fever in ruminants, Republic of Comoros, 2009.

Roger M, Girard S, Faharoudine A, Halifa M, Bouloy M, Cetre-Sossah C, Cardinale E.

Emerg Infect Dis. 2011 Jul;17(7):1319-20. No abstract available.

28.

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.

von Teichman B, Engelbrecht A, Zulu G, Dungu B, Pardini A, Bouloy M.

Vaccine. 2011 Aug 5;29(34):5771-7. doi: 10.1016/j.vaccine.2011.05.055. Epub 2011 Jun 12.

PMID:
21664400
29.

Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin.

Flusin O, Vigne S, Peyrefitte CN, Bouloy M, Crance JM, Iseni F.

Virol J. 2011 May 21;8:249. doi: 10.1186/1743-422X-8-249.

30.

[Crimean-Congo hemorrhagic fever: basics for general practitioners].

Flusin O, Iseni F, Rodrigues R, Paranhos-Baccalà G, Crance JM, Marianneau P, Bouloy M, Peyrefitte CN.

Med Trop (Mars). 2010 Dec;70(5-6):429-38. Review. French.

PMID:
21520641
31.
32.

A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever.

do Valle TZ, Billecocq A, Guillemot L, Alberts R, Gommet C, Geffers R, Calabrese K, Schughart K, Bouloy M, Montagutelli X, Panthier JJ.

J Immunol. 2010 Nov 15;185(10):6146-56. doi: 10.4049/jimmunol.1000949. Epub 2010 Oct 11.

33.

Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran.

Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, Meshkat M, Bouloy M.

Vector Borne Zoonotic Dis. 2010 Oct;10(7):705-8. doi: 10.1089/vbz.2009.0247.

PMID:
20854025
34.

Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes.

Moutailler S, Krida G, Madec Y, Bouloy M, Failloux AB.

Vector Borne Zoonotic Dis. 2010 Oct;10(7):681-8. doi: 10.1089/vbz.2009.0246.

PMID:
20854021
35.

Molecular biology of rift valley Fever virus.

Bouloy M, Weber F.

Open Virol J. 2010 Apr 22;4:8-14. doi: 10.2174/1874357901004020008.

36.

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.

Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, Bouloy M.

Vaccine. 2010 Jun 23;28(29):4581-7. doi: 10.1016/j.vaccine.2010.04.085. Epub 2010 May 12.

PMID:
20470792
37.

Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness.

Maltezou HC, Andonova L, Andraghetti R, Bouloy M, Ergonul O, Jongejan F, Kalvatchev N, Nichol S, Niedrig M, Platonov A, Thomson G, Leitmeyer K, Zeller H.

Euro Surveill. 2010 Mar 11;15(10):19504.

38.

[Role of Toscana virus in meningo-encephalitis in Tunisia].

Bahri O, Fazaa O, Ben Alaya-Bouafif N, Bouloy M, Triki H, Bouattour A.

Pathol Biol (Paris). 2011 Dec;59(6):e125-7. doi: 10.1016/j.patbio.2010.01.003. Epub 2010 Apr 7. French.

PMID:
20378279
39.

First serological investigation of peste-des-petits-ruminants and Rift Valley fever in Tunisia.

Ayari-Fakhfakh E, Ghram A, Bouattour A, Larbi I, Gribâa-Dridi L, Kwiatek O, Bouloy M, Libeau G, Albina E, Cêtre-Sossah C.

Vet J. 2011 Mar;187(3):402-4. doi: 10.1016/j.tvjl.2010.01.007. Epub 2010 Feb 18.

PMID:
20167519
40.

Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects.

Mansuroglu Z, Josse T, Gilleron J, Billecocq A, Leger P, Bouloy M, Bonnefoy E.

J Virol. 2010 Jan;84(2):928-39. doi: 10.1128/JVI.01165-09. Epub 2009 Nov 4.

41.

Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells.

Peyrefitte CN, Perret M, Garcia S, Rodrigues R, Bagnaud A, Lacote S, Crance JM, Vernet G, Garin D, Bouloy M, Paranhos-Baccalà G.

J Gen Virol. 2010 Jan;91(Pt 1):189-98. doi: 10.1099/vir.0.015701-0. Epub 2009 Oct 7.

PMID:
19812268
42.

Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Bouloy M, Flick R.

Antiviral Res. 2009 Nov;84(2):101-18. doi: 10.1016/j.antiviral.2009.08.002. Epub 2009 Aug 12. Review.

43.

Evaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France.

Cêtre-Sossah C, Billecocq A, Lancelot R, Defernez C, Favre J, Bouloy M, Martinez D, Albina E.

Prev Vet Med. 2009 Jul 1;90(1-2):146-9. doi: 10.1016/j.prevetmed.2009.03.011. Epub 2009 Apr 24.

PMID:
19394096
44.

International network for capacity building for the control of emerging viral vector-borne zoonotic diseases: ARBO-ZOONET.

Ahmed J, Bouloy M, Ergonul O, Fooks A, Paweska J, Chevalier V, Drosten C, Moormann R, Tordo N, Vatansever Z, Calistri P, Estrada-Pena A, Mirazimi A, Unger H, Yin H, Seitzer U.

Euro Surveill. 2009 Mar 26;14(12). pii: 19160.

45.

Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV.

Attarzadeh-Yazdi G, Fragkoudis R, Chi Y, Siu RW, Ulper L, Barry G, Rodriguez-Andres J, Nash AA, Bouloy M, Merits A, Fazakerley JK, Kohl A.

J Virol. 2009 Jun;83(11):5735-48. doi: 10.1128/JVI.02440-08. Epub 2009 Mar 18.

46.

Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.

Lagerqvist N, Näslund J, Lundkvist A, Bouloy M, Ahlm C, Bucht G.

Virol J. 2009 Jan 17;6:6. doi: 10.1186/1743-422X-6-6.

47.

Real-time reverse-transcription loop-mediated isothermal amplification for rapid detection of rift valley Fever virus.

Peyrefitte CN, Boubis L, Coudrier D, Bouloy M, Grandadam M, Tolou HJ, Plumet S.

J Clin Microbiol. 2008 Nov;46(11):3653-9. doi: 10.1128/JCM.01188-08. Epub 2008 Sep 17.

48.

RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Billecocq A, Gauliard N, Le May N, Elliott RM, Flick R, Bouloy M.

Virology. 2008 Sep 1;378(2):377-84. doi: 10.1016/j.virol.2008.05.033. Epub 2008 Jul 9.

49.

Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs.

Suspène R, Renard M, Henry M, Guétard D, Puyraimond-Zemmour D, Billecocq A, Bouloy M, Tangy F, Vartanian JP, Wain-Hobson S.

Nucleic Acids Res. 2008 Jul;36(12):e72. doi: 10.1093/nar/gkn295. Epub 2008 May 30.

50.

Spatial and temporal patterning of bank vole demography and the epidemiology of the Puumala hantavirus in northeastern France.

Augot D, Sauvage F, Boue F, Bouloy M, Artois M, Demerson JM, Combes B, Coudrier D, Zeller H, Cliquet F, Pontier D.

Epidemiol Infect. 2008 Dec;136(12):1638-43. doi: 10.1017/S0950268808000423. Epub 2008 Mar 6.

Supplemental Content

Loading ...
Support Center